Analytical Data
-
Gene name
Porcine circovirus 2 Capsid
- Application
-
Species
Porcine circovirus 2
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O56129
-
Expression Region
1-233aa
-
Molecular Weight
32.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Porcine circovirus type 2 (PCV2) is a small, non-enveloped virus that belongs to the Circoviridae family and is primarily associated with various porcine diseases, including post-weaning multisystemic wasting syndrome (PMWS). The PCV2 capsid protein plays a crucial role in viral assembly, immunogenicity, and serotype determination, making it a key target for vaccine development and therapeutic interventions. Research into recombinant PCV2 capsid proteins has gained momentum due to the urgent need for effective vaccines to combat the economic losses caused by PCV2 infections in the swine industry. The use of recombinant DNA technology allows for the expression of the capsid protein in various host systems, facilitating the production of vaccines that can elicit protective immune responses in pigs. Moreover, studies have shown that the capsid protein can serve as an effective antigen for serological assays, enabling the monitoring of PCV2 circulation in livestock populations. Understanding the structure and function of the PCV2 capsid protein is essential for developing targeted strategies to control the virus and improve animal health. Consequently, ongoing research focuses on optimizing production methods, characterizing immune responses, and evaluating the efficacy of capsid-based vaccines in field trials. This research is critical not only for enhancing biosecurity in pig farming but also for reducing the reliance on antibiotics, addressing broader concerns related to animal welfare and public health.
